Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Griffiths

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
The Journal of Investigative Dermatology|April 1, 1988
Cyclosporin A does not inhibit epidermal growth at therapeutic levelsL Fry, B S Baker, C E Griffiths, et al.
The Journal of Clinical Investigation|October 1, 1992
Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitroE A Duell, A Aström, C E Griffiths, et al.
The Journal of Investigative Dermatology|December 18, 1998
Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytesM Rivier, I Safonova, P Lebrun, et al.
Transplantation Proceedings|June 1, 1988
Long-term cyclosporine in the management of psoriasisL Fry, C E Griffiths, A V Powles, et al.
The British Journal of Dermatology|September 1, 1999
Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their qualityD M Ashcroft, A L Wan Po, H C Williams, et al.
The British Journal of Dermatology|September 1, 1999
Tumour necrosis factor-alpha induces Langerhans cell migration in humansM Cumberbatch, C E Griffiths, S C Tucker, et al.
The British Journal of Dermatology|May 3, 2000
The Salford Psoriasis Index: an holistic measure of psoriasis severityB Kirby, D G Fortune, M Bhushan, et al.
The British Journal of Dermatology|September 5, 2001
Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trialS Reitamo, P Spuls, B Sassolas, et al.
Pharmacoeconomics|January 11, 2001
Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasisD M Ashcroft, A Li Wan Po, H C Williams, et al.
Journal of Clinical Pharmacy and Therapeutics|January 6, 1999
Quality of life measures in psoriasis: a critical appraisal of their qualityD M Ashcroft, A Li Wan Po, H C Williams, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
The Journal of Investigative Dermatology|April 1, 1988
Cyclosporin A does not inhibit epidermal growth at therapeutic levelsL Fry, B S Baker, C E Griffiths, et al.
The Journal of Clinical Investigation|October 1, 1992
Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitroE A Duell, A Aström, C E Griffiths, et al.
The Journal of Investigative Dermatology|December 18, 1998
Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytesM Rivier, I Safonova, P Lebrun, et al.
Transplantation Proceedings|June 1, 1988
Long-term cyclosporine in the management of psoriasisL Fry, C E Griffiths, A V Powles, et al.
The British Journal of Dermatology|September 1, 1999
Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their qualityD M Ashcroft, A L Wan Po, H C Williams, et al.
The British Journal of Dermatology|September 1, 1999
Tumour necrosis factor-alpha induces Langerhans cell migration in humansM Cumberbatch, C E Griffiths, S C Tucker, et al.
The British Journal of Dermatology|May 3, 2000
The Salford Psoriasis Index: an holistic measure of psoriasis severityB Kirby, D G Fortune, M Bhushan, et al.
The British Journal of Dermatology|September 5, 2001
Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trialS Reitamo, P Spuls, B Sassolas, et al.
Pharmacoeconomics|January 11, 2001
Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasisD M Ashcroft, A Li Wan Po, H C Williams, et al.
Journal of Clinical Pharmacy and Therapeutics|January 6, 1999
Quality of life measures in psoriasis: a critical appraisal of their qualityD M Ashcroft, A Li Wan Po, H C Williams, et al.
Pageof 21